7 May 2014
Oxford BioTherapeutics Secures Exclusive Global Rights From Amgen and ImmunoG
Oxford BioTherapeutics Takes Exclusive Rights to Use Amgen Xenomouse® Antibodies and ImmunoGen Technology to Develop Novel Antibody-Drug Conjugate for HER2-Negative Breast Cancer … OXFORD, UK and SAN JOSE, CA – 7 May 2014 – Oxford BioTherapeutics, an...
16 April 2014
Critical Pharmaceuticals announces US patent allowance
Critical Pharmaceuticals has announced that the United States Patent and Trademark Office (USPTO) has issued a notice of allowance for a patent application directed towards the Company's CP024 Intranasal Growth Hormone and CP046 Intranasal Teriparatide (parathyroid hormone 1-34)...
11 April 2014
Monica Healthcare secures N'Tech grant
A University of Nottingham spin-out has been awarded a grant of more than £250,000 to support a further £1m investment into the business. Monica Healthcare, based at BioCity, is led by Dr Carl Barratt. The company has developed a foetal and maternal monitor, which is...
8 April 2014
Oxford Cryosystems helps push the boundaries of the known universe
Senior management from Oxfordshire-based business Oxford Cryosystems are celebrating their involvement in a global project to create what will eventually become the largest and most sensitive radio telescope on earth. Directors Richard Glazer and Alex Renshaw joined a delegation...
1 April 2014
Onwards and upwards for BWB Birmingham
2013/14 has been a truly remarkable year for BWB’s Birmingham office. Fuelled by successful appointments on a spate of regionally significant projects such as Severn Trent Water’s HQ in Coventry and Resorts World at the NEC, staff numbers in the office is expected to...
27 March 2014
Sprue Aegis plc (“Sprue”) and Intamac to launch connected safety solution
Intamac Systems Limited announces a new 3 year partnership agreement with Sprue, one of Europe’s leading suppliers of home safety products including smoke and carbon monoxide alarms sold under the FireAngel brand. Under the partnership, Sprue will launch an internet...
19 March 2014
Biofortuna receives FDA clearance of its SSPGo™ line of HLA molecular diagnostic freeze-dried kits
Biofortuna, a UK based molecular diagnostics company with proprietary freeze drying (lyophilizing) technology, has received FDA 510K clearance for its line of SSPGo™ HLA PCR kits. The SSPGo HLA Typing Kits are qualitative DNA-based kits for determining HLA alleles in low...
7 March 2014
New England Biolabs® announces supply agreement with Lumora
5th March, 2014 (Ipswich, MA, USA) New England Biolabs, Inc. (NEB®), a world leader in the production and supply of recombinant enzymes and related reagents for the life science industry, has strengthened its position as a key supplier to the fast-growing molecular...
26 February 2014
Prime Minister David Cameron visits portfolio company Oxford Cryosystems
The Prime Minister, David Cameron, recently visited Oxford Cryosystems in Long Hanborough to meet executives and staff from the market-leading manufacturer of specialist scientific instrumentation and software. During his visit, Mr Cameron toured the production site with...
29 January 2014
Michelson Diagnostics targets malignant melanoma using OCT imaging with €2.3M EU funding
Portfolio company Michelson Diagnostics, the UK based medical device company focused on multi-beam Optical Coherence Tomography (‘OCT’) technology, announces that the European Union has awarded a €2.26 million Framework 7 grant to a consortium of seven partners...